(Q53090157)

11 May 2018

title

Potential of [18F]-fluoromisonidazole positron-emission tomography for radiotherapy planning in head and neck squamous cell carcinomas. (English)

1 reference

11 May 2018

adaptive radiation therapy

main subject

0 references

author

Frederic Lamare

7

1 reference

11 May 2018

author name string

B Henriques de Figueiredo

1

1 reference

11 May 2018

T Merlin

2

1 reference

11 May 2018

H de Clermont-Gallerande

3

1 reference

11 May 2018

M Hatt

4

1 reference

11 May 2018

D Vimont

5

1 reference

11 May 2018

P Fernandez

6

1 reference

11 May 2018

publication date

1 November 2013

1 reference

11 May 2018

Strahlentherapie und Onkologie

published in

1 reference

11 May 2018

volume

189

1 reference

11 May 2018

issue

12

1 reference

11 May 2018

page(s)

1015-1019

1 reference

11 May 2018

Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Intra- and intertumor heterogeneities in total, chronic, and acute hypoxia in xenografted squamous cell carcinomas. Detection and quantification using (immuno-)fluorescence techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Impact of the accuracy of automatic tumour functional volume delineation on radiotherapy treatment planning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Intensity-modulated radiotherapy for prostate cancer implementing molecular imaging with 18F-choline PET-CT to define a simultaneous integrated boost

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Hypoxia dose painting by numbers: a planning study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0454-7

Two or four hour [¹⁸F]FMISO-PET in HNSCC. When is the contrast best?

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24173497

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

PET-guided dose escalation tomotherapy in malignant pleural mesothelioma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24173497

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24173497

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00066-013-0454-7

1 reference

11 May 2018

1 reference

11 May 2018